Xylamidor 20 mg/ml Injektionslösung für Tiere
Xylamidor 20 mg/ml Injektionslösung für Tiere
Authorised
- Xylazine hydrochloride
Product identification
Medicine name:
Xylamidor 20 mg/ml Injektionslösung für Tiere
Active substance:
- Xylazine hydrochloride
Target species:
-
Cattle
-
Dog
-
Cat
-
Horse
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Xylazine hydrochloride23.32/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal1day
-
Milk0hour
-
-
-
Intravenous use
-
Cattle
-
Meat and offal1day
-
Milk0hour
-
-
Horse
-
Meat and offal1day
-
Milk0hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
-
Valid
Authorised in:
-
France
Available in:
-
France
Package description:
- Clear glass vial type I with 5 x 10 ml solution for injection with a coated bromobutyl rubber stopper, type I and aluminium cap in a cardboard box.
- Clear glass vial type II with 25 ml solution for injection with a coated bromobutyl rubber stopper, type I and aluminium cap.
- Clear glass vial type II with 50 ml solution for injection with a coated bromobutyl rubber stopper, type I and aluminium cap.
- Clear glass vial type I with 10 ml solution for injection with a coated bromobutyl rubber stopper, type I and aluminium cap.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Vetviva Richter GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetviva Richter GmbH
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/1685517 3/2023
Date of authorisation status change:
Reference member state:
-
Austria
Procedure number:
- AT/V/0029/001
Concerned member states:
-
Belgium
-
Bulgaria
-
Cyprus
-
Denmark
-
Finland
-
France
-
Germany
-
Greece
-
Ireland
-
Italy
-
Latvia
-
Netherlands
-
Norway
-
Poland
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
Generic of:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025
Summary of Product Characteristics
English (PDF)
Download Published on: 11/08/2023
Updated on: 13/03/2026
French (PDF)
Published on: 14/03/2026
Combined File of all Documents
English (PDF)
Download Published on: 14/03/2026
at-puar-atv0029001-mr-xylaemidoer-en.pdf
English (PDF)
Download Published on: 8/08/2023
Updated on: 13/03/2026